Gov. Glenn Youngkin saved about $7 million in state funds and $40 million in federal funds by vetoing a lower body-mass index ...

Physicians describe common prior authorization challenges when treating patients for obesity and share strategies to overcome ...

Another was a looming late-stage clinical trial of a closely watched pipeline drug that's loaded with potential. For a ...

As summer approaches, millions of Americans are turning to weight-loss injections in hopes of shedding pounds—fast. Roughly ...

GLP-1 medications like Wegovy and Zepbound curb hunger, but can also cut out important nutrients from your diet. Here are ...

AbbVie snagged yet another spot among April’s highest TV ad spenders, as its Vraylar jumped two spots to eighth place with a ...

Hims & Hers Health appoints former Amazon executive Nader Kabbani as its chief operating officer. The telehealth-consultation platform on Monday said Kabbani will oversee operations as the company ...

Three Motley Fool contributors think they've found no-brainer healthcare stocks to buy in May. Here's why they picked Eli ...

On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...

While drugmakers battle over costs, MoveSmarter Health, a U.S. startup launched in Argentina, is sidestepping the fray with a ...

You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...